(Q36915912)

17 August 2017

1 reference

title

Obesity cardiomyopathy: diagnosis and therapeutic implications (English)

1 reference

17 August 2017

0 references

1 reference

Chiew Wong

1

1 reference

PubMed ID

17712361

17 August 2017

Thomas H Marwick

series ordinal

2

1 reference

PubMed ID

17712361

17 August 2017

language of work or name

1 reference

1 September 2007

1 reference

Nature Clinical Practice Cardiovascular Medicine

17 August 2017

1 reference

17 August 2017

4

1 reference

17 August 2017

480-490

1 reference

17 August 2017

9

1 reference

The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening

17 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

Cardiovascular effects of weight reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Evaluation of global and regional left ventricular function with 16-slice computed tomography, biplane cineventriculography, and two-dimensional transthoracic echocardiography: comparison with magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Cardiac structure and function in the obese: a cardiovascular magnetic resonance imaging study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

New Doppler echocardiographic applications for the study of diastolic function

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Alterations of left ventricular myocardial characteristics associated with obesity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Association of subclinical right ventricular dysfunction with obesity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Should we be evaluating the ventricle or the myocardium? Advances in tissue characterization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index >30 kg/m2).

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of exercise and cavity size on right ventricular function in morbid obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Impact of obesity on plasma natriuretic peptide levels

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide are depressed in obesity despite higher left ventricular end diastolic pressures.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Obesity cardiomyopathy: pathogenesis and pathophysiology

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Overweight, obesity, and blood pressure: the effects of modest weight reduction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Diabesity: a polygenic model of dietary-induced obesity from ad libitum overfeeding of Sprague-Dawley rats and its modulation by moderate and marked dietary restriction

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of weight loss on cardiac synchronization and proinflammatory cytokines in premenopausal obese women.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Improvement in left ventricular function after rapid weight loss in obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue Doppler imaging.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Clinical and prognostic implications

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Reduction of left ventricular hypertrophy after exercise and weight loss in overweight patients with mild hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Analysis of GLUT4 distribution in whole skeletal muscle fibers: identification of distinct storage compartments that are recruited by insulin and muscle contractions

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of sibutramine on weight maintenance after weight loss: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Reduction of weight and left ventricular mass with serotonin uptake inhibition in obese patients with systemic hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of weight loss on left ventricular diastolic filling in morbid obesity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effect of weight loss on left ventricular mass in nonhypertensive morbidly obese patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Factors influencing left ventricular systolic function in nonhypertensive morbidly obese patients, and effect of weight loss induced by gastroplasty.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Left ventricular function and cardiopulmonary performance following surgical treatment of morbid obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish Obese Subjects study

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Weight reduction regresses left ventricular mass regardless of blood pressure level in obese subjects.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Antihypertensive therapy with enalapril improves glucose storage and insulin sensitivity in hypertensive patients with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Protective effects of carvedilol in the myocardium

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Lipotoxic heart disease in obese rats: implications for human obesity

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0964

7 January 2021

Identifiers

DOI

10.1038/NCPCARDIO0964

1 reference

17 August 2017

1 reference

PubMed ID

17712361